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Background: Early diagnosis of sepsis and its differentiation from the noninfective SIRS is very important in order
that treatment can be initiated in a timely and appropriate way. In this study we investigated standard
haematological and biochemical parameters and thromboelastography (TEG) in patients who had undergone
surgical resection of the oesophagus to find out if changes in any of these parameters could help in early
differentiation between SIRS and sepsis development.
Methods: We enrolled 43 patients (aged 41–74 years) of whom 38 were evaluable. Blood samples were obtained
on the morning of surgery and then at 24-hour intervals for the next 6 days. Samples were analysed for
procalcitonin (PCT), C-reactive protein (CRP), interleukin-6 (IL- 6), aspartate transaminase (AST), alanine transaminase
(ALT) , lactate, white blood count (WBC), D-dimers, antithrombin (AT), international normalised ratio (INR), activated
partial thromboplastin time (APTT) and parameters of TEG.
Results: Significant differences between patients who developed sepsis during this period (9 patients) and SIRS
were found in ALT on Day 1, in AST on Days 1–4, in PCT on Days 2–6; in CRP on Days 3–6; in IL-6 on Days 2–5; in
leucocytes on Days 2, 3 and 6; and in D-dimers on Days 2 and 4. Significance values ranged from p< 0.0001 to
p< 0.05.
Conclusions: Sequential measurements of ALT, AST, PCT and IL-6 during the early postoperative period can be
used for early differentiation of sepsis and postoperative SIRS after oesophagectomy. Among the coagulation
parameters measured, only D-dimer concentrations appeared to be helpful in this process. TEG does not seem to
be a useful early predictor of sepsis development; however it can be used to differentiate sepsis and SIRS from Day
5 after surgery.
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Sepsis is a common, life-threatening condition in critically
ill patients and, despite the availability of new therapeutic
options for treating it, mortality rates remain high [1].
One reason for this may be delays in reaching a diagnosis
and beginning treatment.
Patients undergoing major surgery often develop post-
operative systemic inflammatory response syndrome
(SIRS) in response to trauma, ischaemia, inflammation
and/or infection. When due to an infection, SIRS may
be self-limiting or may progress to severe sepsis [2]. In* Correspondence: durila4@yahoo.com
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reproduction in any medium, provided the orSIRS, proinflammatory cytokines induce intravascular
coagulation and fibrinolysis is inhibited by production of
plasminogen activator inhibitor 1 [3]. In septic patients
this leads to hypercoagulability and the consumption of
coagulation inhibitors and microthrombi formation with
development of multiple organ dysfunction syndrome
(MODS [4,5]. A marker that could distinguish an
inflammatory septic response from inflammatory non-
infective events would be helpful, therefore, to ensure
that patients receive early treatment.
Biochemical markers that are believed to help in early
diagnosis of sepsis include procalcitonin (PCT), interleukin
1 (IL 1), IL 6, IL 10 and C-reactive protein (CRP), although
reports of sensitivity and specificity differ [6,7]. Thromboe-
lastography (TEG) is a reliable method for evaluatingd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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such as prothrombin time (PT) or activated thromboplastin
time (aPTT), TEG provides information about all phases of
the coagulation process, from initiation of blood clot
formation through fibrinolysis. Moreover, because whole
blood is analysed, TEG takes account of interactions be-
tween all blood components (platelets, coagulation factors,
leucocytes etc.) in the coagulation process.
Some authors have also identified markers of liver dys-
function in patients with SIRS or sepsis [9,10]. The
mechanisms by which this occurs in sepsis involve the
leaking of bacterial products into the systemic circula-
tion, thus promoting the production of proinflammatory
cytokines. Liver dysfunction can therefore be considered
a part of SIRS which characterizes sepsis [11-13].
The aim of our study was to find early diagnostic marker
of sepsis that might help to differentiate septic patients
from patients with non-infective postoperative SIRS. We
investigated changes in biochemical and hematological
parameters during the early postoperative period, in
patients who had undergone surgical oesophagectomy – a
double cavity surgery, which has an accompanying high
risk of postoperative complications, including sepsis, and
is associated with high mortality rates [14].
Methods
Forty three patients undergoing surgical oesophagectomy
with a thoracoabdominal approach were included in this
study. All patients received preoperative chemotherapy
(epirubicin, cisplatin, 5-fluorouracil) ending 3 weeks be-
fore undergoing the operation. Exclusion criteria included
hepatic insufficiency and coagulation disorders. This study
was approved by the Ethics Committee for Multi-Centric
Clinical Trials of the University Hospital Motol, Prague,
Czech Republic. All patients provided informed consent
before inclusion in the study.
Following surgery, all patients were extubated in the
operating theatre and then transferred to the surgical in-
tensive care unit (ICU). Post-surgical medications for all
patients included antibiotics (for the first 48 hours),
thoracic epidural analgesia, Diclofenac 1 x 75 mg/24 h
and 1 x 0.4 ml (40 mg) Clexane (Enoxaparin) at 10 p. m.
Blood samples were obtained from the cubital vein using
the syringe-needle method on the morning and of surgery
and then at 24-hour intervals for the following 6 days. Sam-
ples were analysed for: PCT (Elecsys BRAHMS PCT; Roche
Diagnostics, Mannheim, Germany); IL- 6 (EIA IL-6;
IMMUNOTECH, Marseille, France); lactate (Cobas Integra
400+; Roche, Switzerland); CRP, aspartate transaminase
(AST) and alanine transaminase (ALT) (all Advia 1800; Sie-
mens, USA). White blood count (WBC) (Coulter LH 750
Hematology Analyzer; Beckman-Coulter, Miami, FL); and
antithrombin (AT) activity, D-dimer concentration, inter-
national normalized ratio (INR) and activated partialthromboplastin time (aPTT) (all CA-7000 automated co-
agulation analyzer; Sysmex; Kobe, Japan). TEG analysis was
conducted with a computer-controlled thrombelastograph
haemostasis system (TEG Haemoscope, Niles, IL) using na-
tive cuvettes (without heparinase) and the native method
(non-activated, without kaolin). Recently TEG is being vali-
dated as a tool for assessment of coagulation abnormalities
in sepsis [15,16]
Patients who fulfilled the criteria of sepsis defined by
ACCP-SCCM conference [17] during this period formed
the ‘septic’ group. Other patients formed the ‘non-septic’
group. The ICU doctors, who were in charge of the def-
inition and division of the patients into the groups, were
blinded to the results of the study tests.
(6) The laboratory results of all investigated para-
meters mentioned above were compared between the
two groups every day. For those parameters, in which
singnificant diferences were found during the first 3 days,
cutoff points for differentiations between sepsis and
non-sepsis were set up.
Statistical analysis
Statistical analysis was performed using Prism 5.0 statis-
tical software (Graph Pad Software, Inc.). Values were
tested for normality of distribution. Results are reported
as mean ± SEM. We used parametrical tests for normally
distributed data, unpaired t-tests for comparisons of the
two groups, repeated-measures analysis of variance
(ANOVA) with Bonferroni´s multiple comparison test
for analyses within a group and the Pearson coefficient
for correlation analyses. In non-normally distributed
data, the differences between two groups were tested
using the Mann–Whitney test and the Friedman test
with Dunn´s multiple comparison for comparison of
repeated measurements within a group. Correlations
were expressed using the Spearman correlation coeffi-
cient. A P value of less than 0.05 was considered statisti-
cally significant. A receiver operating characteristics
(ROC) curve was used for every parameter to find opti-
mal value with best specificity and sensitivity with
respect to discrimination of sepsis from non-sepsis.
Results
In all, 43 patients were enrolled in the study: four
patients were excluded because the surgery did not
proceed as planned, and one patient withdrew from
study. Among the evaluable patients, there were seven
females and 31 males ranging in age from 41 to 74 years.
Prior to surgery, the overall mean Acute Physiology and
Chronic Health Evaluation II (APACHE II) score was 4
(range 0–9)., APACHE II scores tended to be higher in
patients who went on to develop sepsis, but the scores
were not significantly different to those in the non-
sepsis group (mean 4.4 vs. 3.8, respectively; p = 0.36).
Figure 1 Mean postoperative changes in serum AST (A) and ALT (B). Changes from day of surgery (D0) to Day 6 after surgery (D6) in the
septic (S) and nonseptic (NS) groups. There are significant differences between the S and NS groups from as early as the day after surgery.
* indicates p< 0.05. ** indicates p< 0.01. ***indicates p< 0.001.
Table 2 Cutoff points (generated from ROC curves) for
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All patients developed SIRS within 48 hours following
surgery. Subsequently nine out of 38 patients (23.7 %)
started to develop sepsis within the next 4 days after sur-
gery. Five of these had pneumonia diagnosed from
clinical symptoms (cough, expectorating coloured spu-
tum and sepsis criteria) and confirmed by X-ray. In the
four remaining cases dehiscence of the gastroesophageal
anastomosis (diagnosed by radiology examination of the
esophagus and confirmed by surgical revision of thorax)
was the cause of sepsis. The median time to sepsis diag-
nosis was 3 days. According to our findings detectable
changes in laboratory markers could be found as soon as
24–48 hours before diagnosis.
Estimates of liver function
Changes in the levels of serum AST and ALT are shown
in Figure 1A and 1B for 6-days period. Levels of AST
and ALT in patients in the septic group were statistically
significantly higher than in the non-septic groups from
the 1-st day after surgery. For AST this difference per-
sisted to Day 4 (values of p ranged from <0.002 to
0.006).
Cutoff points for early diagnosis of development of
postoperative infectious complications within 6 days of
surgery are shown in Tables 1, 2 and 3 (for the 1-st three
days).Table 1 Cutoff points (generated from ROC curves) for
early diagnosis of postoperative infectious complication
and its prediction within 6 days for Day 1 postsurgery
Day 1 Cutoff Sensitivity ( %) Specificity ( %)
AST ukat/l >0.7 100 34.48
>1.13 88.89 72.41
>2.96 44.44 100
ALT ukat/l >0.29 100 4.17
>0.94 77.78 75
>3.79 22.22 100Biochemical parameters
Figure 2 shows changes in serum levels of PCT, lactate,
IL-6 and CRP. On Day 2 after surgery, levels of PCT
(p = 0.03), IL-6 (p< 0.03) and lactate (p< 0.006) in
patients in the septic group were statistically significantly
higher than in the non-septic group. In the case of PCT,
the magnitude of the difference increased over time,
reaching p = 0.0001 at Day 6 (Figure 2A). IL-6 levels
remained higher until Day 5 (Figure 2C) Differences in
the levels of CRP in the septic and non-septic groups
were statistically significantly different on Day 3 (p
< 0.04) and remained so until Day 6 (Figure 2D).
Cutoff points for early diagnosis of development of
postoperative infectious complications within 6 days of
surgery are shown in Tables 2 and 3 (for days 2 and 3
after surgery).
Haematological and coagulation parameters
Changes in serum levels of LY30 (ie the percentage of
coagulum lysed in the TEG analysis at 30 minutes after
the maximal strength of clot), D-dimers AT III, INR and
leucocytes are shown in Figure 3. Differences in serum
concentrations of leucocytes in the septic and non-septic
groups were just statistically significantly different onearly diagnosis of postoperative infectious complication
and its prediction within 6 days for Day 2 postsurgery
Day 2 Cutoff Sensitivity (%) Specificity (%)
AST ukat/l >0.54 100 34.48
>1.03 77.78 75.86
>2.92 11.11 96.55
PCT ug/l >0.25 100 3.45
>3.18 77.78 75.86
>5.65 55.56 96.55
IL-6 ng/l >148.8 100 41.38
>273.8 77.78 82.76
>499.3 22.22 100
Table 3 Cutoff points (generated from ROC curves) for
early diagnosis of postoperative infectious complication
and its prediction within 6 days for Day 3 postsurgery
Day 3 Cutoff Sensitivity (%) Specificity (%)
AST ukat/l >0.47 88.89 41.38
>0.77 66.67 82.76
>1.28 33.33 100
PCT ug/l >0.28 100 13.79
>2.02 77.78 79.31
>3.31 55.56 96.55
IL-6 ng/l >43.72 100 10.34
>134.7 77.78 86.21
>219.8 44.44 96.55
CRP mg/l >143.3 100 48.28
>174.6 66.67 68.97
>269.5 11.11 100
Durila et al. BMC Anesthesiology 2012, 12:12 Page 4 of 7
http://www.biomedcentral.com/1471-2253/12/1/12Days 2 (p< 0.03), 3 (p< 0.05) and 6 (p< 0.03)
(Figure 2E). Statistically significantly higher concentra-
tions of D-dimers were found on Days 2 and 4 (p< 0.02
and p = 0.03, respectively). Levels of INR, AT III and
LY30 were statistically significantly higher in the septic
group on Days 4, 5 and 6 respectively (p = 0.03 for INR
and AT III; p< 0.04 for LY30).
Discussion
Patients who have undergone major surgery are at high
risk of developing complications associated with sepsisFigure 2 Mean postoperative changes in serum PCT (A); lactate (B); IL
surgery (D6) in the septic (S) and nonseptic (NS) groups. PCT and IL-6 are s
p< 0.05. ** indicates p< 0.01. ***indicates p< 0.001.[14,18]; however, differentiation between postoperative
SIRS and septic complications is difficult. Long-term
prophylaxis with high-dose antibiotics or wide-spectrum
antibiotics, which might prevent the development of
sepsis, may obscure the host response and induce the
development of resistance. Identification of septic
patients at the beginning of the process can help in
better and more specific diagnostic and therapeutic pro-
cedures and overall management. On the contrary, ex-
clusion of sepsis might help in better and rationale
antibiotics treatment.
In our study, we investigated both hematological
(including TEG) and biochemical markers of sepsis, as
there is a link between inflammation and coagulation
(5). We also examined markers of liver dysfunction be-
cause of the important role reported to be played by the
liver in sepsis. This is a very interesting finding and is, in
all probability, underestimated in practice. Interestingly,
levels of AST and ALT were significantly higher in the
septic group of patients compared with the nonseptic
group, and those changes could be detected as early as
the first day after surgery and persisted to the fourth day
(see Figure 1). For cutoff points for early diagnosis of de-
velopment of postoperative infectious complications
within 6 days of surgery see Tables 1, 2 and 3.
Our findings of higher liver enzymes levels in septic
patients are in accordance with findings of others who
say that liver dysfunction is common in patients with
sepsis, ranging from mild elevations of serum amino-
transferases to severe cholestasis [11-13,19,20]. However,-6 (C); CRP (D). Changes from day of surgery (D0) to Day 6 after
tatistically significant in the S and NS groups from D2. * indicates
Figure 3 Mean postoperative changes in serum D-dimers (A); ATIII (B); INR (C); LY-30 (D); and leucocytes (E). Changes in concentrations
of haematological and coagulation factors in the septic (S) and non-septic (NS) groups from day of surgery (D0) to Day 6 after surgery (D6).
Suprisingly, TEG is not an early predictor of sepsis development. * indicates p< 0.05.
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be a cofactor participating in sepsis development. Liver
has a central role in the regulation of host defenses. It
serves as a source of inflammatory mediators and is a
major site of the removal of bacteria and endotoxins
from systemic circulation. Kupffer cells (KCs) of the liver
make up 80 %-90 % of the fixed-tissue macrophages of
the reticuloendothelial system. KCs take up bacteria,
endotoxins and are stimulated to release a wide range of
products implicated in liver injury, such as tumor necro-
sis factor, interleukin-1 and interleukin- 6 [12]. It is pro-
posed that Kupffer cell phagocytic depression associated
with liver dysfunction permits spread of endotoxin and
inflamatory mediators and thus predisposes to sepsis
and multiple organ failure.
The cause of postoperative liver dysfunction in our
patients is not known. All patients had received the same
kind of anaesthesia (isofluran, remifentanil, rocuronium)
and postoperative care and there are some reports ofisofluran side effect on liver function [21]. Transient
hypotension and hypoxia cannot be ruled out and individ-
ual response of the patient to surgery can also play a part.
That could have played a role in development of ,,posta-
naesthetic hepatitis” and subsequently in development of
sepsis. Importantly, unlike the expensive tests used for
detection of inflammatory markers, measurements of liver
dysfunction are cheap and routinely available and can be
helpful in screening of patients susceptible to sepsis for
early signs of sepsis development.
Overall, the earliest markers of the development of
sepsis seem to be AST and ALT. Differences in PCT and
IL-6 in septic and non-septic patients with SIRS are de-
tectable from Day 2 (see Figure 2). For cutoff points for
early diagnosis of development of postoperative infec-
tious complications within 6 days of surgery see Tables 2
and 3. Both parameters showed similar trends on subse-
quent days, which means that, as IL-6 is measured
mostly experimentally, measurements of PCT should be
Figure 4 The evolution and changes in platelet counts and
fibrinogen level over time in the septic (S) and non-septic (NS)
groups from day of surgery (D0) to Day 6 after surgery (D6).
No significant differences. *means sign of multiplication.
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colleagues actually found that PCT is better for monitor-
ing the development of sepsis in patients who had
undergone oesophageal surgery for carcinoma; however
they were able to predict sepsis one day earlier than in
our study [22]. Unlike our patients though, their patients
did not receive preoperative chemotherapy. In another
study, Mokart and colleagues investigated PCT and IL-6
to predict sepsis development in patients who had
undergone gastrointestinal or gynaecological tumour
resections. They were also able to predict the develop-
ment of sepsis from as early as Day 1 after surgery,
although levels of IL-6 and PCT were not as high as
those of our patients [7]. It should be noted, however,
that unlike our patients, those patients had only under-
gone surgery in the abdominal cavity.
When it comes to CRP, we found significant differ-
ences between the groups from Day 3, when CRP levels
in the septic group rose by comparison with those of
patients in the non-septic group (see Figure 2). For
cutoff points for early diagnosis of development of post-
operative infectious complications within 6 days of sur-
gery see Table 3. This finding is similar to that described
by Ito, although the differences were not statisticallysignificant in that study. Although it is questionable just
how valuable this marker is for early diagnosis of sepsis,
the tests are cheap and can help in sepsis diagnosis.
Surprisingly, among the coagulation parameters, only
concentrations of D-dimers were statistically significantly
higher during the early postoperative period (from Day 2
to Day 4). However, since the concentrations of D-dimers
subsequently decreased (Figure 3A), the value of this mar-
ker for early diagnosis of sepsis is questionable.
Because this kind of operation is not very often, the
sample size might be the limitation of this study. How-
ever, we were able to find some interesting laboratory
changes in patients who would develop infectious com-
plication untill the 6-th postoperative day, as soon as the
1-st postoperative day, no matter if sepsis was diagnosed
on day 3 or 6. This findings could attract our attention
to those patients in the risk of sepsis development more
then 24 hours before sepsis diagnosis.
We also evaluated changes in pletelets count and
fibrinogen level in both groups during the investigation
time period, but there was no significant difference be-
tween their values (p> 0.05) (Figure 4).
Our finding of decreased fibrinolytic activity (repre-
sented by levels of LY30) in the septic group versus the
non-septic group is in accordance with those of a recent
study by Adamzik and colleagues. This group investi-
gated coagulation changes in septic patients using TEG
and also found decreased fibrinolytic activity [23]. In
that study, TEG did not detect changes until 24 hours
after severe sepsis had been diagnosed and the patients
were in a much more serious condition than ours. In
both our study and the Adamzik study then, patients
had already developed sepsis before TEG detected
changes in fibrinolysis. Thus, while TEG is useful to
diagnose sepsis in later state, it is not useful for early
diagnosis of sepsis or predicting which patients will go
on to develop sepsis.
Conclusions
Sequential measurements of ALT, AST, PCT and IL-6
during the early postoperative period can be used for
early differentiation of sepsis and postoperative SIRS
after oesophagectomy. Among the coagulation para-
meters measured, only D-dimer concentrations appeared
to be helpful in this process. TEG does not seem to be a
useful early predictor of sepsis development; however it
can be used to differentiate sepsis and SIRS from Day 5
after surgery.
We can conclude that sequential measurements of
biochemical parameters, such as AST, ALT, PCT and IL-6,
during the early postoperative period can be useful for the
early diagnosis of sepsis development and its prediction
following oesophagectomy, and to differentiate sepsis from
postoperative SIRS. Among coagulation parameters, only
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process. By contrast, TEG does not seem to be helpful as
an early diagnostic marker of sepsis development; how-
ever, it can be used to differentiate between sepsis and
SIRS from Day 5 after surgery.
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